FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer
The U.S. Food and Drug Administration has approved a treatment for pancreatic cancer that, in clinical trials, nearly doubled patients’ overall survival time. The drug, daraxonrasib, sold under the brand name Rasonque and manufactured by Revolution Medicines, appears to be a breakthrough in the treatment of one of the world’s deadliest cancers. A late-stage clinical … Read more